News
EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
MD Medical Group Investments Plc: MD Medical Group Annual report 2022
MD Medical Group Investments Plc: MD Medical Group maintains strong EBITDA margin
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
EQS-News: MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Eckert & Ziegler: Successful fiscal year 2022
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research Institute Scientist, Kathryn Wolhuter
Agilent Technologies Inc. (NYSE: A) announced today that the recipient of the 2023 Darlene Solomon Award is Kathryn Wolhuter, Ph.D., a senior postdoctoral researcher studying coronary heart disease
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Tom West to Inogen’s Board of
David A. Jones Elected Chairman of the Humana Foundation Board of Directors
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors
LivaNova to Announce First-Quarter 2023 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2023 results on Wednesday, May 3, 2023 at 1 p.m
EQS-News: Sernova: Abstract on First Cohort of its Phase 1/2 Study Involving Islet Transplantation into Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions
Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call
Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the second quarter of fiscal year 2023, the period ended February 28, 2023, after the close of the
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc